Tadalafil's Top 3 Emerging Medical Uses Beyond ED

Beyond treating erectile dysfunction, tadalafil (Cialis) has received FDA approval for other significant medical conditions and is being actively researched for further therapeutic applications.

The top 3

1. Pulmonary Arterial Hypertension Treatment: Tadalafil (marketed as Adcirca) was FDA-approved in 2009 for the treatment of pulmonary arterial hypertension (PAH), improving exercise ability in patients by widening blood vessels in the lungs.
2. Benign Prostatic Hyperplasia Symptom Relief: The FDA approved tadalafil (Cialis) in 2011 for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), a condition where an enlarged prostate causes urinary issues.
3. Potential for Heart Failure Treatment: Research, including studies in sheep, suggests that tadalafil may be biologically effective as a treatment for heart failure by altering signaling pathways to restore the heart's ability to respond to adrenaline, with some limited human evidence also indicating potential benefits.

Sources

• FDA approves tadalafil to treat benign prostatic hyperplasia
• FDA Approves Tadalafil for Benign Prostatic Hyperplasia - MDEdge
• FDA Approves ADCIRCA (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension | Fierce Biotech
• Sex drug 'effective' as heart failure treatment | The University of Manchester
• FDA approves combination therapy tablet for pulmonary arterial hypertension - Healio
• Tadalafil: A PDE5 Inhibitor for Erectile Dysfunction, BPH, and Pulmonary Arterial Hypertension - Superpower

Open the full topic